NCT06745908
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06745908
Title ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors ImmunityBio, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group RECRUITING Springdale Arkansas 72762 United States Details
Chan Soon-Shiong Institute for Medicine RECRUITING El Segundo California 90245 United States Details
OPN Healthcare INC RECRUITING Glendale California 91203 United States Details
OPN Healthcare INC/ Cancer and Blood Specialty Clinic RECRUITING Los Alamitos California 90720 United States Details
The Oncology Institute of Hope and Innovation RECRUITING Fort Lauderdale Florida 33316 United States Details
Moffit Cancer Center RECRUITING Tampa Florida 33612-9497 United States Details
Emory University - Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
University of Cincinnati Medical Center RECRUITING Cincinnati Ohio 45267 United States Details
Vanderbilt - Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field